Literature DB >> 21902670

New insights into the mechanisms of mitochondrial preconditioning-triggered neuroprotection.

Sónia C Correia1, Susana Cardoso, Renato X Santos, Cristina Carvalho, Maria S Santos, George Perry, Mark A Smith, Paula I Moreira.   

Abstract

Mitochondria fulfill a number of essential cellular functions, being recognized that the strict regulation of the structure, function and turnover of these organelles is an immutable control node for the maintenance of neuronal integrity and homeostasis. Many lines of evidence posit that mitochondria constitute a convergence point of preconditioning - a paradigm that affords robust brain tolerance in the face of neurodegenerative insults. Indeed, it has been described that preconditioning activates an adaptive reprogramming of mitochondrial biology in response to a noxious stress-stimulus, which in turn will contribute to augment both mitochondrial and neuronal tolerance. Mitochondrial reactive species (ROS), mitochondrial ATP-sensitive potassium (mitoK(ATP)) channels and mitochondrial permeability transition pore have been identified as specific mitochondrial mediators and targets of the adaptive program underlying preconditioning. Recent studies further link mitochondrial biogenesis, dynamics and mitophagy to preconditioning, thereby representing novel mechanisms by which preconditioning may mediate brain tolerance. The present review summarizes the current views on how mitochondrial biology is linked to preconditioning-induced neuroprotection. A better understanding of the mitochondrial mechanisms underlying preconditioning will help in the development of novel therapeutic approaches with the primary goal of modulating mitochondria to enhance brain tolerance against neurodegenerative events.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21902670     DOI: 10.2174/138161211798072490

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  14 in total

1.  Alleviating brain stress: what alternative animal models have revealed about therapeutic targets for hypoxia and anoxia.

Authors:  Sarah L Milton; Ken Dawson-Scully
Journal:  Future Neurol       Date:  2013

Review 2.  The Oxygen Paradox, the French Paradox, and age-related diseases.

Authors:  Joanna M S Davies; Josiane Cillard; Bertrand Friguet; Enrique Cadenas; Jean Cadet; Rachael Cayce; Andrew Fishmann; David Liao; Anne-Laure Bulteau; Frédéric Derbré; Amélie Rébillard; Steven Burstein; Etienne Hirsch; Robert A Kloner; Michael Jakowec; Giselle Petzinger; Delphine Sauce; Florian Sennlaub; Isabelle Limon; Fulvio Ursini; Matilde Maiorino; Christina Economides; Christian J Pike; Pinchas Cohen; Anne Negre Salvayre; Matthew R Halliday; Adam J Lundquist; Nicolaus A Jakowec; Fatima Mechta-Grigoriou; Mathias Mericskay; Jean Mariani; Zhenlin Li; David Huang; Ellsworth Grant; Henry J Forman; Caleb E Finch; Patrick Y Sun; Laura C D Pomatto; Onnik Agbulut; David Warburton; Christian Neri; Mustapha Rouis; Pierre Cillard; Jacqueline Capeau; Jean Rosenbaum; Kelvin J A Davies
Journal:  Geroscience       Date:  2017-12-21       Impact factor: 7.713

3.  Mitochondrial biogenesis contributes to ischemic neuroprotection afforded by LPS pre-conditioning.

Authors:  R Anne Stetler; Rehana K Leak; Wei Yin; Lili Zhang; Suping Wang; Yanqin Gao; Jun Chen
Journal:  J Neurochem       Date:  2012-11       Impact factor: 5.372

4.  Is exercise-in-a-bottle likely to proffer new insights into Alzheimer's disease?

Authors:  Sónia C Correia; George Perry; Rudy Castellani; Paula I Moreira
Journal:  J Neurochem       Date:  2013-10       Impact factor: 5.372

Review 5.  Oxygen Sensing and Signaling in Alzheimer's Disease: A Breathtaking Story!

Authors:  Sónia C Correia; Paula I Moreira
Journal:  Cell Mol Neurobiol       Date:  2021-09-12       Impact factor: 5.046

6.  Conditioning Against the Pathology of Parkinson's disease.

Authors:  Rehana K Leak
Journal:  Cond Med       Date:  2018-04-28

7.  The role of neuroglobin in the neuroprotection of limb ischemic preconditioning in rats.

Authors:  Shu-Qin Li; Wen-Bin Li; Min Zhang; Yu-Zhou Wu; Yu-Yan Hu
Journal:  Mol Neurobiol       Date:  2012-11-21       Impact factor: 5.590

8.  Maximizing neuroprotection: where do we stand?

Authors:  Damien P Kuffler
Journal:  Ther Clin Risk Manag       Date:  2012-04-10       Impact factor: 2.423

9.  Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3?

Authors:  Michel de Lorgeril; Patricia Salen; Pascal Defaye; Mikael Rabaeus
Journal:  BMC Med       Date:  2013-01-04       Impact factor: 8.775

10.  Subcellular expression and neuroprotective effects of SK channels in human dopaminergic neurons.

Authors:  A M Dolga; A de Andrade; L Meissner; H-G Knaus; M Höllerhage; P Christophersen; H Zischka; N Plesnila; G U Höglinger; C Culmsee
Journal:  Cell Death Dis       Date:  2014-01-16       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.